Loading...
Header Logo
Keywords
Last Name
Institution

Randall Prince

TitleProfessor
InstitutionUniversity of Houston
DepartmentPharm Prac & Trans Research
Address4800 Calhoun Rd
Houston TX 77004
Phone832-842-8389
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Rolston KV, Jamal MA, Nesher L, Shelburne SA, Raad I, Prince RA. In vitro activity of ceftaroline and comparator agents against Gram-positive and Gram-negative clinical isolates from cancer patients. Int J Antimicrob Agents. 2017 Apr; 49(4):416-421. PMID: 28257904.
      View in: PubMed
    2. Rolston KV, Wang W, Nesher L, Smith JR, Rybak MJ, Prince RA. Time-kill determination of the bactericidal activity of telavancin and vancomycin against clinical methicillin-resistant Staphylococcus aureus isolates from cancer patients. Diagn Microbiol Infect Dis. 2017 Apr; 87(4):338-342. PMID: 28109549.
      View in: PubMed
    3. Aitken SL, Tarrand JJ, Deshpande LM, Tverdek FP, Jones AL, Shelburne SA, Prince RA, Bhatti MM, Rolston KVI, Jones RN, Castanheira M, Chemaly RF. High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-ß-lactamase Production in Enterobacteriaceae Bloodstream Infections at a Major Cancer Center. Clin Infect Dis. 2016 Oct 01; 63(7):954-958. PMID: 27313265.
      View in: PubMed
    4. Rolston KV, Wang W, Nesher L, Shelburne SA, Prince RA. In vitro activity of dalbavancin and five comparator agents against common and uncommon Gram-positive organisms isolated from cancer patients. J Antibiot (Tokyo). 2016 05; 69(5):381-7. PMID: 26626876.
      View in: PubMed
    5. Kassamali Z, Prince RA, Danziger LH, Rotschafer JC, Rhomberg PR, Jones RN. Microbiological Assessment of Polymyxin B Components Tested Alone and in Combination. Antimicrob Agents Chemother. 2015 Dec; 59(12):7823-5. PMID: 26392511; PMCID: PMC4649206.
      View in: PubMed, PubMed Central
    6. Rolston K, Wang W, Nesher L, Coyle E, Shelburne S, Prince RA. In vitro activity of telavancin compared with vancomycin and linezolid against Gram-positive organisms isolated from cancer patients. J Antibiot (Tokyo). 2014 Jul; 67(7):505-9. PMID: 24824818.
      View in: PubMed
    7. Kassamali Z, Rotschafer JC, Jones RN, Prince RA, Danziger LH. Reply to Nation et al. Clin Infect Dis. 2013 Dec; 57(11):1657-8. PMID: 23934308.
      View in: PubMed
    8. Kassamali Z, Rotschafer JC, Jones RN, Prince RA, Danziger LH. Polymyxins: wisdom does not always come with age. Clin Infect Dis. 2013 Sep; 57(6):877-83. PMID: 23728146.
      View in: PubMed
    9. Rolston KV, Kapadia M, Tarrand J, Coyle E, Prince RA. Spectrum of gram-positive bacteraemia and in vitro activities of daptomycin, linezolid and vancomycin against organisms isolated from cancer patients. Int J Antimicrob Agents. 2013 Jun; 41(6):516-20. PMID: 23481658.
      View in: PubMed
    10. Lewis RE, Albert NP, Liao G, Wang W, Prince RA, Kontoyiannis DP. High-dose induction liposomal amphotericin B followed by de-escalation is effective in experimental Aspergillus terreus pneumonia. J Antimicrob Chemother. 2013 May; 68(5):1148-51. PMID: 23349440.
      View in: PubMed
    11. Chaftari AM, Hachem RY, Ramos E, Kassis C, Campo M, Jiang Y, Prince RA, Wang W, Raad II. Comparison of posaconazole versus weekly amphotericin B lipid complex for the prevention of invasive fungal infections in hematopoietic stem-cell transplantation. Transplantation. 2012 Aug 15; 94(3):302-8. PMID: 22814329.
      View in: PubMed
    12. Lewis RE, Liao G, Wang W, Prince RA, Kontoyiannis DP. Voriconazole pre-exposure selects for breakthrough mucormycosis in a mixed model of Aspergillus fumigatus-Rhizopus oryzae pulmonary infection. Virulence. 2011 Jul-Aug; 2(4):348-55. PMID: 21788730.
      View in: PubMed
    13. Lewis RE, Liao G, Hou J, Prince RA, Kontoyiannis DP. Comparative in vivo dose-dependent activity of caspofungin and anidulafungin against echinocandin-susceptible and -resistant Aspergillus fumigatus. J Antimicrob Chemother. 2011 Jun; 66(6):1324-31. PMID: 21486855.
      View in: PubMed
    14. Mihu CN, Rhomberg PR, Jones RN, Coyle E, Prince RA, Rolston KV. Escherichia coli resistance to quinolones at a comprehensive cancer center. Diagn Microbiol Infect Dis. 2010 Jul; 67(3):266-9. PMID: 20471765.
      View in: PubMed
    15. Yuan Z, Ledesma KR, Singh R, Hou J, Prince RA, Tam VH. Quantitative assessment of combination antimicrobial therapy against multidrug-resistant bacteria in a murine pneumonia model. J Infect Dis. 2010 Mar 15; 201(6):889-97. PMID: 20156065.
      View in: PubMed
    16. Lewis RE, Albert ND, Liao G, Hou J, Prince RA, Kontoyiannis DP. Comparative pharmacodynamics of amphotericin B lipid complex and liposomal amphotericin B in a murine model of pulmonary mucormycosis. Antimicrob Agents Chemother. 2010 Mar; 54(3):1298-304. PMID: 20038620; PMCID: PMC2826015.
      View in: PubMed, PubMed Central
    17. Stein GE, El-Mortada M, Smith C, Dybas L, Prince R, Havlichek D. Fungicidal activity of anidulafungin in serum from patients does not correlate to its susceptible breakpoint against Candida spp. J Antimicrob Chemother. 2010 Feb; 65(2):374-6. PMID: 19996140.
      View in: PubMed
    18. Singh R, Ledesma KR, Chang KT, Hou JG, Prince RA, Tam VH. Pharmacodynamics of moxifloxacin against a high inoculum of Escherichia coli in an in vitro infection model. J Antimicrob Chemother. 2009 Sep; 64(3):556-62. PMID: 19589810.
      View in: PubMed
    19. Tam VH, Hou J, Kwa AL, Prince RA. Comment on: Development and validation of a reversed-phase high-performance liquid chromatography assay for polymyxin B in human plasma. J Antimicrob Chemother. 2009 Mar; 63(3):627-8; author reply 628-9. PMID: 19022780.
      View in: PubMed
    20. Lim TP, Ledesma KR, Chang KT, Hou JG, Kwa AL, Nikolaou M, Quinn JP, Prince RA, Tam VH. Quantitative assessment of combination antimicrobial therapy against multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2008 Aug; 52(8):2898-904. PMID: 18505848; PMCID: PMC2493134.
      View in: PubMed, PubMed Central
    21. Vemulakonda GA, Hariprasad SM, Mieler WF, Prince RA, Shah GK, Van Gelder RN. Aqueous and vitreous concentrations following topical administration of 1% voriconazole in humans. Arch Ophthalmol. 2008 Jan; 126(1):18-22. PMID: 18195213.
      View in: PubMed
    22. Andes D, Diekema DJ, Pfaller MA, Prince RA, Marchillo K, Ashbeck J, Hou J. In vivo pharmacodynamic characterization of anidulafungin in a neutropenic murine candidiasis model. Antimicrob Agents Chemother. 2008 Feb; 52(2):539-50. PMID: 18070979; PMCID: PMC2224754.
      View in: PubMed, PubMed Central
    23. Kwa AL, Lim TP, Low JG, Hou J, Kurup A, Prince RA, Tam VH. Pharmacokinetics of polymyxin B1 in patients with multidrug-resistant Gram-negative bacterial infections. Diagn Microbiol Infect Dis. 2008 Feb; 60(2):163-7. PMID: 17916420.
      View in: PubMed
    24. Lewis RE, Liao G, Hou J, Chamilos G, Prince RA, Kontoyiannis DP. Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis. Antimicrob Agents Chemother. 2007 Apr; 51(4):1253-8. PMID: 17261624; PMCID: PMC1855500.
      View in: PubMed, PubMed Central
    25. Lewis RE, Chamilos G, Prince RA, Kontoyiannis DP. Pretreatment with empty liposomes attenuates the immunopathology of invasive pulmonary aspergillosis in corticosteroid-immunosuppressed mice. Antimicrob Agents Chemother. 2007 Mar; 51(3):1078-81. PMID: 17194825; PMCID: PMC1803112.
      View in: PubMed, PubMed Central
    26. Wiederhold NP, Tam VH, Chi J, Prince RA, Kontoyiannis DP, Lewis RE. Pharmacodynamic activity of amphotericin B deoxycholate is associated with peak plasma concentrations in a neutropenic murine model of invasive pulmonary aspergillosis. Antimicrob Agents Chemother. 2006 Feb; 50(2):469-73. PMID: 16436698; PMCID: PMC1366892.
      View in: PubMed, PubMed Central
    27. Hariprasad SM, Shah GK, Mieler WF, Feiner L, Blinder KJ, Holekamp NM, Gao H, Prince RA. Vitreous and aqueous penetration of orally administered moxifloxacin in humans. Arch Ophthalmol. 2006 Feb; 124(2):178-82. PMID: 16476886.
      View in: PubMed
    28. Lewis RE, Wiederhold NP, Prince RA, Kontoyiannis DP. In vitro pharmacodynamics of rapid versus continuous infusion of amphotericin B deoxycholate against Candida species in the presence of human serum albumin. J Antimicrob Chemother. 2006 Feb; 57(2):288-93. PMID: 16387749.
      View in: PubMed
    29. Wiederhold NP, Kontoyiannis DP, Prince RA, Lewis RE. Attenuation of the activity of caspofungin at high concentrations against candida albicans: possible role of cell wall integrity and calcineurin pathways. Antimicrob Agents Chemother. 2005 Dec; 49(12):5146-8. PMID: 16304189; PMCID: PMC1315970.
      View in: PubMed, PubMed Central
    30. Lewis RE, Wiederhold NP, Lionakis MS, Prince RA, Kontoyiannis DP. Frequency and species distribution of gliotoxin-producing Aspergillus isolates recovered from patients at a tertiary-care cancer center. J Clin Microbiol. 2005 Dec; 43(12):6120-2. PMID: 16333108; PMCID: PMC1317213.
      View in: PubMed, PubMed Central
    31. Hariprasad SM, Shah GK, Chi J, Prince RA. Determination of aqueous and vitreous concentration of moxifloxacin 0.5% after delivery via a dissolvable corneal collagen shield device. J Cataract Refract Surg. 2005 Nov; 31(11):2142-6. PMID: 16412929.
      View in: PubMed
    32. Walker P, Neuhauser MN, Tam VH, Willey JS, Palmer JL, Bruera E, Prince RA. Subcutaneous administration of cefepime. J Pain Symptom Manage. 2005 Aug; 30(2):170-4. PMID: 16125032.
      View in: PubMed
    33. Gauthier GM, Nork TM, Prince R, Andes D. Subtherapeutic ocular penetration of caspofungin and associated treatment failure in Candida albicans endophthalmitis. Clin Infect Dis. 2005 Aug 01; 41(3):e27-8. PMID: 16007519.
      View in: PubMed
    34. Wiederhold NP, Coyle EA, Raad II, Prince RA, Lewis RE. Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of gram-positive catheter-related bacteraemia. J Antimicrob Chemother. 2005 May; 55(5):792-5. PMID: 15814598.
      View in: PubMed
    35. Hariprasad SM, Blinder KJ, Shah GK, Apte RS, Rosenblatt B, Holekamp NM, Thomas MA, Mieler WF, Chi J, Prince RA. Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous. Arch Ophthalmol. 2005 Jan; 123(1):39-44. PMID: 15642810.
      View in: PubMed
    36. Lewis RE, Wiederhold NP, Chi J, Han XY, Komanduri KV, Kontoyiannis DP, Prince RA. Detection of gliotoxin in experimental and human aspergillosis. Infect Immun. 2005 Jan; 73(1):635-7. PMID: 15618207; PMCID: PMC538950.
      View in: PubMed, PubMed Central
    37. Wiederhold NP, Kontoyiannis DP, Chi J, Prince RA, Tam VH, Lewis RE. Pharmacodynamics of caspofungin in a murine model of invasive pulmonary aspergillosis: evidence of concentration-dependent activity. J Infect Dis. 2004 Oct 15; 190(8):1464-71. PMID: 15378439.
      View in: PubMed
    38. Hsue G, Napier JT, Prince RA, Chi J, Hospenthal DR. Treatment of meningeal coccidioidomycosis with caspofungin. J Antimicrob Chemother. 2004 Jul; 54(1):292-4. PMID: 15190025.
      View in: PubMed
    39. Hariprasad SM, Mieler WF, Holz ER, Gao H, Kim JE, Chi J, Prince RA. Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans. Arch Ophthalmol. 2004 Jan; 122(1):42-7. PMID: 14718293.
      View in: PubMed
    40. Hariprasad SM, Mieler WE, Shah GK, Blinder KJ, Apte RS, Holekamp NM, Thomas MA, Chi J, Prince RA. Human intraocular penetration pharmacokinetics of moxifloxacin 0.5% via topical and collagen shield routes of administration. Trans Am Ophthalmol Soc. 2004; 102:149-55; discussion 155-7. PMID: 15747753; PMCID: PMC1280095.
      View in: PubMed, PubMed Central
    41. Lewis RE, Kontoyiannis DP, Darouiche RO, Raad II, Prince RA. Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection. Antimicrob Agents Chemother. 2002 Nov; 46(11):3499-505. PMID: 12384356; PMCID: PMC128760.
      View in: PubMed, PubMed Central
    42. Lewis RE, Prince RA, Chi J, Kontoyiannis DP. Itraconazole preexposure attenuates the efficacy of subsequent amphotericin B therapy in a murine model of acute invasive pulmonary aspergillosis. Antimicrob Agents Chemother. 2002 Oct; 46(10):3208-14. PMID: 12234846; PMCID: PMC128771.
      View in: PubMed, PubMed Central
    43. Kontoyiannis DP, Tarrand J, Prince R, Samonis G, Rolston KV. Effect of fluconazole on agar invasion by Candida albicans. J Med Microbiol. 2001 Jan; 50(1):78-82. PMID: 11192509.
      View in: PubMed
    44. Kontoyiannis DP, Lewis RE, Sagar N, May G, Prince RA, Rolston KV. Itraconazole-amphotericin B antagonism in Aspergillus fumigatus: an E-test-based strategy. Antimicrob Agents Chemother. 2000 Oct; 44(10):2915-8. PMID: 10991890; PMCID: PMC90181.
      View in: PubMed, PubMed Central
    45. Baldwin JC, Miller CC, Prince RA, Espada R. Chest radiograph heterogeneity predicts functional improvement with volume reduction surgery. Ann Thorac Surg. 2000 Oct; 70(4):1208-11. PMID: 11081872.
      View in: PubMed
    46. Prince RA, Lucas DS, Fox JL. Effect of a dual-lumen peripheral catheter on the delivery of known incompatible medications. Ann Pharmacother. 1998 Sep; 32(9):875-7. PMID: 9762372.
      View in: PubMed
    47. Griver AR, Prince RA, Darouiche RO. A simple method for administering vancomycin in the spinal cord injured population. Arch Phys Med Rehabil. 1997 May; 78(5):459-62. PMID: 9161361.
      View in: PubMed
    48. Anaissie EJ, Kontoyiannis DP, Huls C, Vartivarian SE, Karl C, Prince RA, Bosso J, Bodey GP. Safety, plasma concentrations, and efficacy of high-dose fluconazole in invasive mold infections. J Infect Dis. 1995 Aug; 172(2):599-602. PMID: 7622915.
      View in: PubMed
    49. Huls CE, Prince RA, Seilheimer DK, Bosso JA. Pharmacokinetics of cefepime in cystic fibrosis patients. Antimicrob Agents Chemother. 1993 Jul; 37(7):1414-6. PMID: 8363368; PMCID: PMC187985.
      View in: PubMed, PubMed Central
    50. Bosso JA, Prince RA. Anti-anaerobic antimicrobial agents: cefoxitin, cefotetan, clindamycin, and metronidazole. Tex Heart Inst J. 1990; 17(2):77-85. PMID: 15227388; PMCID: PMC326456.
      View in: PubMed, PubMed Central
    51. Barriere SL, Dudley MN, Kowalsky SF, Kreter B, Polk RE, Prince RA, Tartaglione T. The role of the pharmacist in antimicrobial agent therapy. J Infect Dis. 1989 Mar; 159(3):593-4. PMID: 2915174.
      View in: PubMed
    52. Fick RB, Alexander MR, Prince RA, Kasik JE. Penetration of cefotaxime into respiratory secretions. Antimicrob Agents Chemother. 1987 May; 31(5):815-7. PMID: 3606080; PMCID: PMC174841.
      View in: PubMed, PubMed Central
    53. Perry PJ, Browne JL, Prince RA, Alexander B, Tsuang MT. Effects of smoking on nortriptyline plasma concentrations in depressed patients. Ther Drug Monit. 1986; 8(3):279-84. PMID: 3750370.
      View in: PubMed
    54. Richards ML, Prince RA, Kenaley KA, Johnson JA, LeFrock JL. Antimicrobial penetration into cerebrospinal fluid. Drug Intell Clin Pharm. 1981 May; 15(5):341-68. PMID: 7023900.
      View in: PubMed
    55. Prince RA, Le Frock JL, Jacknowitz AI. Antimicrobial usage in patients with renal impairment. W V Med J. 1976 Jun; 72(6):130-4. PMID: 1064244.
      View in: PubMed
    Prince's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (238) concept(s)
    _
    Co-Authors Expand Description
    See all (2) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department
    Physical Neighbors Expand Description
    _